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Abstract
Transcription factors are key components of regulatory networks that control development, as well as the response to
environmental stimuli. We have established an experimental pipeline in Caenorhabditis elegans that permits global
identification of the binding sites for transcription factors using chromatin immunoprecipitation and deep sequencing. We
describe and validate this strategy, and apply it to the transcription factor PHA-4, which plays critical roles in organ
development and other cellular processes. We identified thousands of binding sites for PHA-4 during formation of the
embryonic pharynx, and also found a role for this factor during the starvation response. Many binding sites were found to
shift dramatically between embryos and starved larvae, from developmentally regulated genes to genes involved in
metabolism. These results indicate distinct roles for this regulator in two different biological processes and demonstrate the
versatility of transcription factors in mediating diverse biological roles.
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Introduction
A major scientific endeavor is aimed toward understanding how
the regulatory information embedded in the genome is deployed to
direct the complex process of development [1]. With the completion
of the genomic sequence of many model organisms, much effort is
now focused on identifying the precise regions of the genome that
regulate specific developmental events. Of particular interest are
regions that serve as binding sites for developmentally important
transcription factors. Through these sites, a transcription factor
controls the spatial and temporal expression of genes that function in
diverse developmental processes. Identification of the DNA binding
sites of a factor links it to its direct target genes, and permits a fuller
understanding of the mechanisms by which different transcription
factors control the development of an organism.
Ultimately, understanding transcriptional regulation of devel-
opment requires identification of the regulatory network as a
whole. The binding sites of many transcription factors under
similar conditions must be determined, as well as how binding sites
for a given transcription factor change over time as development
progresses. To this end, we have developed a high-throughput
experimental system to categorize the binding sites of many
transcription factors using chromatin immunoprecipitation (ChIP)
in the developmental model organism, the nematode C. elegans.
C. elegans provides many advantages to deciphering develop-
mental regulatory networks [2]. The invariant cell lineage of C.
elegans provides an excellent framework to interpret how regulatory
networks control development. Additionally, the spatial and
temporal expression of both transcription factors and their targets
can be followed using live GFP imaging techniques. The small size
and simple growth conditions of C. elegans facilitate large-scale
biochemical analyses such as ChIP. Finally, because the genome is
relatively compact, individual genes are small and close together,
which simplifies multiple steps of the process, from cloning
procedures to downstream bioinformatics analysis.
We have established an experimental system to systematically
tag C. elegans transcription factor genes with a fluorescent epitope
tag, create transgenic animals expressing a tagged factor, and
perform chromatin immunoprecipitation followed by deep
sequencing (ChIP-Seq) to identify binding sites for that factor
PLoS Genetics | www.plosgenetics.org 1 February 2010 | Volume 6 | Issue 2 | e1000848[3,4]. We first applied this approach to the large subunit of RNA
polymerase II, AMA-1, and demonstrate that tagged AMA-1 can
recapitulate binding by endogenous AMA-1. We then focused on
the sequence-specific transcription factor PHA-4/FOXA because
of its well-studied role as a master regulator of pharynx
development during embryogenesis [5–7], as well as a novel role
in improved survival under starvation conditions that we describe
here. We identified binding sites for PHA-4/FOXA under two
developmental conditions: during embryogenesis and during the
first stage of larval development (L1) under starvation conditions.
We found that the binding sites and associated gene targets of
PHA-4 in embryogenesis are generally associated with organ
development, whereas the targets in L1 are primarily associated
with metabolism, reflecting the expected biology of each condition.
Interestingly, we find that several targets preferentially bound in
starved L1s are involved in autophagy. These data establish that
we have laid the foundation for systematic identification of
genome-wide transcription factor binding sites during C. elegans
development and demonstrate new roles for key regulators in
diverse biological processes.
Results
Establishing a pipeline for systematic analysis of
transcription factor binding sites
Identification of binding sites in vivo is critical to understand
how transcription factors operate in regulatory networks to control
development. We therefore have established a pipeline to facilitate
this endeavor in C. elegans (Figure 1). To briefly summarize, we first
generated constructs in which each transcription factor is tagged in
frame with a dual GFP:3xFLAG tag at the carboxyl terminus. This
tag provides both direct visual evidence of spatial and temporal
expression in vivo, as well as two different epitopes that can be
utilized for biochemical experiments. We used recombineering to
insert the tag directly into a fosmid that contains the entire locus of
interest as well as extensive flanking regions (Sarov et al., in prep).
This approach increases the likelihood that the transcription factor
will have the essential regulatory information to allow it to be
expressed correctly in vivo.
These constructs were introduced into worms via microparticle
bombardment, which produces animals bearing low-copy number,
integrated transgenes [8]. We then isolated lines carrying an
integrated transgene, and examined them for expression of the
GFP-tagged factor by fluorescence microscopy. We determined
the developmental stage at which maximal expression occurs, as
well as whether the transcription factor is localized to the nucleus
as expected. Additionally, we examined the size of the tagged
transgenic protein by immunoblot analysis using both anti-FLAG
and anti-GFP antibodies. Finally, we tested whether the protein
can be immunoprecipitated with an antibody to GFP (anti-GFP;
Materials and Methods), followed by immunoblot analysis.
If all of these quality control measures were passed, we then
grew the transgenic animals to the desired developmental time,
harvested and crosslinked the sample, and performed chromatin
immunoprecipitation (ChIP) using anti-GFP to collect chromatin
preferentially bound by the GFP-tagged factor [9]. This chromatin
was then subjected to Illumina-based sequencing, as was non-
immunoprecipitated (input) chromatin from the same sample,
which served as a control.
Figure 1. Experimental pipeline for identification of transcrip-
tion factor binding sites in C. elegans. Individual transcription
factors encoded within fosmids are tagged with a dual green
fluorescent protein (GFP) and 3xFLAG tag at its C-terminus. A construct
is then bombarded into worms to generate a series of integrated
transgenic lines expressing the tagged factor. The expression of each
transcription factor is confirmed through both fluorescence imaging
and immunoblot analysis. The binding sites of each transcription factor
are then identified using chromatin immunoprecipitation followed by
high-throughput sequencing (ChIP-Seq).
doi:10.1371/journal.pgen.1000848.g001
Author Summary
The C. elegans transcription factor PHA-4 is a member of
the highly conserved FOXA family of transcription factors.
These factors act as master regulators of organ develop-
ment by controlling how genes are turned off and on as
tissues are formed. Additionally they regulate genes in
response to nutrient levels and control both longevity and
survival of the organism. However, the extent to which
these factors control similar or distinct gene targets for
each of these functions is unknown. For this reason, we
have used the technique of chromatin immunoprecipita-
tion followed by deep sequencing (ChIP–Seq), to define
the target binding sites of PHA-4 on a genome-wide scale,
when it is either functioning as an organ identity regulator
or in response to environmental stress. Our data clearly
demonstrate distinct sets of biologically relevant target
genes for the transcription factor PHA-4 under these two
different conditions. Not only have we defined PHA-4
targets, but we established an experimental ChIP–Seq
pipeline to facilitate the identification of binding sites for
many transcription factors in the future.
Stage-Specific PHA-4 Binding Profiles
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native AMA-1
We examined whether a transgenic tagged factor could
recapitulate the binding sites of the endogenous, untagged factor.
To directly compare the binding properties of a tagged factor
expressed from a transgene with that of the endogenous protein, we
first performed ChIP for both the tagged and native versions of
AMA-1, the large subunit of RNA polymerase II (RNA Pol II).
AMA-1 is well-suited for this comparison because commercially
available antibodies against RNA Pol II recognize C. elegans AMA-1,
and perform well in ChIP assays [10,11]. Additionally, AMA-1 is
abundantly expressed in the nucleus of all cells of the animal [12,13].
We therefore established a transgenic strain that expresses
AMA-1:GFP:3xFLAG (referred to as AMA-1:GFP thereafter) in
all nuclei, recapitulating the wild type expression pattern (Figure
S1A). We grew duplicate populations of AMA-1:GFP animals to
the L4 stage, which was chosen to provide a stringent test case, as
it provides a particularly biologically complex stage that can be
difficult to replicate. We then performed ChIP using two different
antibodies: anti-GFP, which recognizes the tagged AMA-1, and
anti-Pol II (8WG16, pan-Pol II), which recognizes both tagged and
native proteins in both phosphorylated and non-phosphorylated
forms (Figure S1B). The DNA from each immunoprecipitation
was purified and the ends subjected to sequencing using the
Illumina platform, as was input DNA isolated from crosslinked
and sonicated cells (non-immunoprecipitated). The binding
profiles of both samples were determined and then compared
(Figure 2A; Figure S1C). The overall correlation between anti-
GFP and anti-Pol II ChIP samples was extremely high (0.934;
Figure 2B), indicating that the tagged AMA-1:GFP had a binding
Figure 2. Binding patterns of GFP-tagged AMA-1 are highly similar to that of native AMA-1. (A) Signal tracks of AMA-1 binding profiles
for a representative stretch of chromosome I. The top track represents binding of AMA-1:GFP as detected by anti-GFP. The middle track represents
binding of AMA-1 and AMA-1:GFP as detected by anti-RNA Pol II (8WG16). The bottom track represents input chromatin. (B) Signal values (relative
abundance of sequencing tags in ChIP DNA versus input) for each binding site (p,0.001) in the anti-GFP and anti-8WG16 IPs were subjected to
Pearson correlation coefficient analysis across 600 bp windows. The linear correlation coefficient between the two samples is 0.934.
doi:10.1371/journal.pgen.1000848.g002
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correlation between IPs performed on the same biological samples
was higher than that for IPs performed with the same antibody on
different biological replicates (Figure S1C). Importantly, the
tagged AMA-1 did not exhibit significant ectopic binding sites
not found with endogenous RNA Pol II, indicating that the
transgenic system does not induce a major increase of non-specific
binding. Moreover, the binding sites identified in the two samples
have the similar characteristic of broad peaks distributed over the
length of the gene, as expected for genes undergoing active
transcription (Figure S2). We conclude that the addition of the
GFP:3xFLAG tag does not disrupt the ability of AMA-1 to interact
with its endogenous target genes, and that our anti-GFP antibody
works very well in ChIP experiments in C. elegans.
PHA-4 chromatin immunoprecipitation identifies
thousands of binding sites
We next determined the binding sites for a key transcription
factor, PHA-4/FOXA. PHA-4 is a master organ identity gene that
is required for the specification and formation of the pharynx. The
expression of several hundred genes in the developing embryonic
pharynx is dependent upon PHA-4, many of which are likely
direct targets [14,15]. Moreover, PHA-4 is required continuously
after birth [14] and plays a role in diet-induced longevity in adults,
in the absence of another FOX family transcription factor, DAF-
16 [16,17].
In addition to these previously described functions, we
discovered an additional function for PHA-4 in promoting the
survival of first stage larvae (L1) undergoing starvation (Figure 3).
L1 animals were transiently subjected to pha-4(RNAi) or a negative
control Cherry(RNAi) and incubated in the absence of food
(Materials and Methods). After eight days of starvation, larvae
were transferred to food and tested for their ability to mature
beyond the L1 stage. pha-4(RNAi) animals exhibited a significantly
reduced survival rate at 30%, compared to 75% from the negative
control (Figure 3A). However, no difference in survival was
observed for up to four days of starvation, indicating that pha-
4(RNAi) larvae were healthy, and had not suffered developmental
defects (data not shown). Conversely, transgenic expression of pha-
4 from its native promoter was sufficient to prolong starvation
survival relative to a control, from a mean survival of 8.360.2 days
in wild type to 9.460.2 days in a strain expressing tagged PHA-4
(Figure 3B). Thus, PHA-4 participates in diverse biological
processes at different stages of development, with roles in
embryonic pharynx development, L1 starvation survival, and
adult longevity.
To identify PHA-4 binding sites in the genome, PHA-
4:GFP:3xFLAG (referred to as PHA-4:GFP thereafter) transgenic
animals were created via our pipeline. Animals bearing an
integrated transgene had nuclear-localized expression in the
pharynx and intestine in embryos, and in pharynx, intestine and
rectum in larvae, confirming published expression patterns [5–
7,18] (Figure 4A). Moreover, immunoblot analysis using anti-GFP
demonstrated a tagged protein somewhat larger than 90kD, the
approximate size expected of the largest PHA-4 isoform
containing the GFP:3xFLAG tag (Figure 4B). Finally, we crossed
animals bearing the PHA-4:GFP transgene to pha-4(q90) mutants,
and rescued the embryonic lethality of these mutants.
To compare the binding patterns of PHA-4 under different
conditions, we collected and crosslinked PHA-4:GFP transgenic
animals during embryogenesis when the pharynx is forming, and
during the L1 larval stage under starvation conditions. Biologically
independent duplicate samples were collected. The samples were
immunoprecipitated with anti-GFP to identify PHA-4 binding
sites, and also with anti-RNA Pol II antibodies to identify the
location of RNA Pol II, which will help to define the
transcriptional state of genes associated with PHA-4. The
immunoprecipitated chromatin, along with control input DNA
from the same animals, was then sequenced to the depth of .10
6
reads per sample. Figure 4C shows the binding patterns of PHA-4
and RNA Pol II at both developmental times for a representative
region of the genome, as well as a closer view of the binding
patterns at the gene smk-1. smk-1 encodes a potential co-factor for
PHA-4 [16]; our data suggest that it might also be a regulatory
target of PHA-4 (Figure 4D). We also collected RNA from wild
type embryos and L1 samples and performed cDNA deep
sequencing [19] to identify expressed genes through an indepen-
dent method.
Using a peak-scoring algorithm [20], we identified discrete
PHA-4 binding sites for each sample. A total of 4350 and 4808
binding sites were defined in embryos and starved L1 larvae,
respectively (p,10
25; Table 1 and Dataset S1, S2). We found a
high correlation between replicate experiments for each stage (0.85
Figure 3. PHA-4 is required for starvation survival. (A) Loss of
pha-4 leads to reduced starvation survival of first stage (L1) larvae. Wild-
type (WT) worms were soaked in no RNAi, Cherry double-stranded RNA
(dsRNA), or pha-4 dsRNA without food for the indicated times. To
determine viability, triplicate samples were transferred to plates with
food. Numbers of worms surviving past L1 were counted after 2 days.
Results are an average of three independent experiments, n=300–500
worms counted for each strain per experiment, error bars represent
standard error. *=p,0.05. (B) Overexpression of pha-4 increases L1
starvation survival. PHA-4:GFP and outcrossed WT worms were
subjected to starvation in liquid. Survival was determined as in (A).
Results are an average of two independent experiments, n=500–1900
worms counted for each strain per experiment, error bars represent
standard error, p,0.0001 log rank (Mantel-Cox) test.
doi:10.1371/journal.pgen.1000848.g003
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target-calling algorithm (Figure S3) to assign these binding sites to
candidate gene targets. Genes within 2 kb of a binding site were
designated as candidate regulatory targets of PHA-4, which
resulted in the assignment of over 90% of the sites to one or more
genes (Figure 5A). A binding site could be assigned to more than
one gene if it fell within a gene-dense interval (Materials and
Methods). In total, 4816 protein-coding genes are candidate PHA-
4 targets in embryos, and 4621 genes are candidate PHA-4 targets
in L1 larvae. Only 280 binding sites lie .5 kb from annotated
genes. Presumably these either act a distance or regulate genes that
have not yet been annotated, such as non-protein coding genes.
Overall, these data indicate that PHA-4 has a broad role in
directly regulating the expression of many genes in the C. elegans
genome, in agreement with previously published studies [14].
We used several methods to validate these binding sites. We first
used ChIP-qPCR to directly test whether we could detect enriched
binding of PHA-4 at 94 individual candidate sites taken from both
Figure 4. Identification of PHA-4 binding sites in embryos and starved L1 larvae. (A) PHA-4:GFP is expressed primarily in the pharynx and
gut in embryos and L1s. (B) PHA-4:GFP is enriched upon immunoprecipitation by anti-GFP relative to input and is not immunoprecipitated by a
control IgG antibody. (C) Signal tracks demonstrating specific PHA-4:GFP binding sites on chromosome V. Green track – PHA-4:GFP (GFP antibody);
maroon track – RNA Pol II (8WG16 antibody); blue track – input control; purple track – mapped reads from RNA sequencing data. Embryonic data set
shown on top, L1 larval dataset shown below. (D) Close-up of smk-1 locus showing that PHA-4 binding changes between stages, although the gene
appears to be expressed at both stages. Other examples of PHA-4 binding are shown in Figure S5.
doi:10.1371/journal.pgen.1000848.g004
Stage-Specific PHA-4 Binding Profiles
PLoS Genetics | www.plosgenetics.org 5 February 2010 | Volume 6 | Issue 2 | e1000848embryonic and L1 data sets (Table S1). We found that 76% of the
embryonic sites and 74% of L1 sites were reproducibly enriched
two-fold or higher by ChIP-qPCR of a biologically independent
replicate. Thus, many PHA-4 binding sites identified by ChIP-Seq
are verified through an independent detection method. Addition-
ally, we compared our results to an earlier expression analysis that
had identified genes expressed during pharynx development in
embryos [14] (Figure S4, Materials and Methods). We compared
our list of genes to the list of known of pharynx development genes
and found that over 38% were bound by PHA-4 in our embryonic
ChIP-Seq experiment, which is significantly higher compared to a
randomized set (90/238; p,1.7610
213). Moreover, seven of these
pharynx-expressed genes had been previously demonstrated to be
bound directly by PHA-4 using a gel shift assay [14], and six of the
seven were bound by PHA-4 in our experiments at sites containing
the previously identified PHA-4 consensus sequence.
Table 1. Summary of PHA-4 binding sites and gene targets.
Total binding sites Total targeted genes
1 Targeted genes for GO Analysis
1,2 Unique targets
embryos 4350 4816 4342 (2487)
3 1975 (1328)
Starved L1s 4808 4612 4043 (2062) 1676 (905)
1p value is less than 1610
25.
2The binding site is within the gene or less than 2kb to the 59 end of gene.
3The value in the parentheses is the number of genes annotated by GO.
doi:10.1371/journal.pgen.1000848.t001
Figure 5. Characterization of PHA-4 binding patterns and gene targets. (A) The distribution of the distance between PHA-4 binding sites
and candidate gene targets (Figure S3 for algorithm for assigning gene targets). (B) Scatter plot comparing similarity and uniqueness of PHA-4
binding profile in embryos and L1 larvae. Signal strength is sequenced reads normalized against input in the peak region (p,10
25). (C,D) Gene
Ontology (GO) categories showing the highest level of enrichment for the candidate target genes of PHA-4 specific to embryos (C) and L1 larvae (D).
Fold enrichment is defined as the increase in abundance in the immunoprecipitated sample relative to total input chromatin.
doi:10.1371/journal.pgen.1000848.g005
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peaks to identify de novo consensus binding sequences enriched
under the peaks relative to the genome. Five of the six consensus
sequences identified in either of the two stages were variations of
the known PHA-4 binding consensus sequence TRTTKRY [14],
primarily TGTBTSY (B=[TGC], S=[GC], Y=[TC], p,10
24)
(Figure S5). Intriguingly, the PHA-4 binding site sequence in
embryos differs from those identified in starved L1s. Moreover, a
second, unrelated site was identified in embryos that was not found
in starved L1s, GAGAGAG/C (3.3-fold; p,10
226). This GAGA
element, was previously noted as associated with timing of
pharynx development in embryos [15]. The GAGA sequence
was not enriched among PHA-4 binding sites in starved L1 larvae,
or in a control dataset consisting of HTZ-1 binding peaks [11],
indicating that it is specific to the PHA-4 embryo dataset. These
observations suggest that PHA-4 might have different co-factors at
the two developmental stages that direct it to distinct targets and
distinct binding sites in response to developmental and environ-
mental cues. We conclude that many of the global PHA-4 binding
sites we have identified likely reflect functionally relevant binding
events in the C. elegans genome.
PHA-4 binding profiles are developmentally regulated
To determine the degree to which binding sites change under
different conditions, we compared the PHA-4 binding profiles at
the two stages (Figure 5B). The two datasets exhibit extensive
overlap (2367 targets), but also have many sites present in one
stage but not the other. Of the PHA-4 embryogenesis targets, 1975
(45%) are not found on the list of PHA-4 L1 targets, while 1676
(41%) of PHA-4 L1 targets are not found among the embryo set.
This observation indicates that the binding profile of PHA-4 shifts
substantially under distinct developmental conditions.
To globally categorize the types of genes that are differentially
regulated, we determined the Gene Ontology (GO) functional
categories that are enriched among each set of stage-specific PHA-
4 targets (Figure 5C and 5D). We found that the embryo set is
enriched for developmental processes, whereas the L1 set of targets
is enriched for metabolic processes and defense responses (Table
S2 and Table S3). Although these functional categories are quite
broad, this shift in the basic functions of the targets is consistent
with the shift in the function of PHA-4 from organ development to
an altered metabolic response to promote survival of starvation
conditions.
To investigate these differences in greater detail, we individually
annotated a subset of candidate gene targets. We first selected
target genes based on the presence of strong binding sites
(p,10
210) 0–2kb upstream of the gene, in the candidate
regulatory region. The subset of those targets that had already
been assigned a three-letter name, and presumably had some
functional information available, were then divided into common,
embryo-only, and starved L1-only sets consisting of 202, 312, and
294 genes, respectively (Dataset S3). We explored gene function by
reviewing available data summaries in public databases, such as
Wormbase, and noting multiple trends and distinctions between
the datasets (Table S4). Many genes throughout all three datasets
have been described as expressed in pharynx or intestine, or are
known to have a role in muscle development or function.
Additionally, genes encoding ribosomal proteins are targeted in
all three datasets, with the most found in the common, or shared,
dataset. Intriguingly, multiple components of the RNAi pathway
are also candidate PHA-4 targets, as are splicing regulatory
factors.
Several striking differences were obvious between the two
developmental conditions we examined. For instance, the target
set in embryos includes many components of G-protein signaling,
but the L1 set was devoid of this signaling pathway. Conversely,
the L1 set had multiple examples of modulators of the TGFb-
signaling pathway, which is involved in controlling both body size
and dauer formation [21], whereas the embryo set did not.
Additionally, the embryo set contains many genes that encode
chromatin regulators, including multiple members of the SynMuv
B pathway, NuRD components, and histone modifying proteins.
Intriguingly, multiple members of the dosage compensation
machinery are apparently targeted by PHA-4 binding in embryos,
such as dpy-22, dpy-27, dpy-30, and sdc-2. In contrast to the embryo
set, the L1 set of targets with likely roles in transcription primarily
consist of sequence-specific transcription factors rather than
chromatin-modifying proteins. Most notably, over five times as
many nuclear hormone receptors were bound by PHA-4 in
starved L1s compared to embryos (28 vs. 5, respectively).
Additionally, the metabolism-related factors in starved L1s consist
largely of multiple regulators of sterol and fatty-acid metabolism,
as well as cytochrome P450 and glutathione-S-transferase
components. The starved L1 set also include several components
involved in acetylcholine metabolism and signaling, which is
involved in neuromuscular synapse transmission. Starved L1s also
have increased PHA-4 binding at various types of membrane-
bound proteins, including several multidrug resistance proteins, P-
glycoproteins, tetraspanins, and serpentine receptors. Many fewer
of these types of proteins were noted in the shared or embryo sets.
This shift in functions between stages is exemplified by PHA-4
target genes involved in autophagy. Autophagy in multicellular
organisms can be induced by environmental stresses including
food limitation. Moreover, autophagy genes are essential for dauer
development and life-span extension by diet restriction in C. elegans
[22–24]. Recent genetic assays indicate that the autophagic
response to dietary restriction is a transcriptionally regulated
response that requires PHA-4 activity [24]. Four genes known to
be involved in autophagy (bec-1, lgg-1, gpd-2, and unc-51) and found
that all four are strongly bound by PHA-4 in starved L1 larvae, but
PHA-4 exhibits minimal binding in embryos (Figure S6). Thus,
our data suggest that PHA-4 is directly involved in inducing the
expression of autophagy genes in response to starvation.
PHA-4 preferentially associates with transcriptionally
poised or active genes
We then correlated gene expression levels with PHA-4 binding
using the RNA-sequencing data we gathered in embryos and L1
larvae. Overall, we found that 87% of genes bound by PHA-4 at
either stage are expressed, indicating that PHA-4 rarely functions
as a repressor at either stage. In support of this observation, we
found that the expression levels of 74% of the embryo-specific
PHA-4 target transcripts decreased in L1 larvae, when PHA-4 is
no longer bound. The converse is also true: 69% of the L1-specific
PHA-4 targets are expressed at lower levels in embryos, when
PHA-4 is no longer bound (Figure 6). This finding indicates that
PHA-4 might be directly involved in promoting the expression of
most of its gene targets.
Finally, we tested whether RNA Pol II ‘‘stalling’’ at transcription
start sites (TSS) is affected by binding of PHA-4 in a stage-specific
fashion. Stalling is the accumulation of RNA Pol II at the TSS,
and has been experimentally defined as the presence of a peak of
RNA Pol II binding at the TSS that is four-fold higher than
binding within the gene body [25]. Stalling occurs preferentially at
developmentally or environmentally regulated genes, presumably
to hold RNA Pol II poised to respond rapidly upon the
appearance of the appropriate cue. Stalling has been observed at
,10% of genes in Drosophila and C. elegans previously [25,26], but
Stage-Specific PHA-4 Binding Profiles
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stalling in embryos and L1 larvae, likely due to experimental and
culture differences (Dataset S4 and S5). However, PHA-4 binding
clearly occurs at stalled genes at both stages more frequently than
expected (Figure 7). Of the 277 genes with RNA Pol II stalling in
L1 larvae, 49% are bound by PHA-4, which is twice the fraction of
genes bound by PHA-4 genome-wide (23%). This effect was even
more pronounced in embryos. Among the 251 genes with RNA
Pol II stalling in embryos, 85% are bound by PHA-4, despite
PHA-4 binding to only 20% of genes in the genome. This
observation is consistent with the idea that PHA-4 regulates genes
in response to developmental and environmental cues that
influence the spatial and temporal regulation onset of gene
expression.
Discussion
We have established a pipeline to identify transcription factor
binding sites in vivo in C. elegans. This pipeline is designed to take
advantage of the stability of fosmid-based transgenes, as well as
their reliability in reproducing native expression patterns. The
transgenic lines emerging from this pipeline tend to have between
one and three copies of the transgene, and exhibit minimal, if any,
over-expression (Sarov et al., in prep). Our initial trials with the
RNA polymerase II subunit AMA-1 indicate that the transgenic,
tagged version of a transcriptional regulator can indeed success-
fully recapitulate the DNA binding properties of the native factor.
This pipeline can now be used on additional factors, and because
the same antibody is used for every immunoprecipitation, will
provide fairly uniform investigation of the binding sites of multiple
factors, and aid in the dissection of regulatory networks in
development.
As a first step toward this major goal, we identified candidate
gene targets of PHA-4 in vivo at two distinct developmental stages.
We chose PHA-4 as the initial factor for binding site identification
for three primary reasons. First, it is a well-characterized factor
with fundamentally important, yet distinct, functions at different
times in development. Second, a handful of direct transcriptional
targets of PHA-4 have been independently identified and
validated, providing some key positive controls. Finally, PHA-4,
unlike AMA-1, is expressed tissue-specifically, primarily in
digestion-related tissues such as the pharynx and intestine. Thus,
it provides a test case for whether ChIP can be performed on
transcription factors with restricted expression.
A little over half of the PHA-4 targets we identified are in
common between these two stages, suggesting that PHA-4 does
have a general function in regulation of gene expression. However,
over 40% are preferentially bound in one stage relative to the
other, indicating that the ability of PHA-4 to mediate different
processes likely occurs through a shift in the sets of targets it
regulates. These data indicate that transcription factors can have
diverse and key roles in distinct biological processes and
underscore the importance of identifying binding sites under
multiple conditions.
Several interesting differences in PHA-4 binding were noted
between the two stages. For instance, among the many examples
listed, several genes encoding members of the dosage compensa-
tion complex were preferentially bound by PHA-4 in embryos
relative to L1s. During embryogenesis, PHA-4 helps specify the
pharynx at the same time that the dosage compensation complex
(DCC) is beginning to implement a two-fold reduction of
transcription levels from the entire X chromosome. Little is
known about how the dosage compensation complex interacts
with tissue-specific programs, and our data suggests that PHA-4
helps to control the levels of the DCC in order to provide more or
less dosage compensation in that tissue as needed. Possibly, master
regulators in other tissues also regulate DCC levels in order to
bring the level of dosage compensation in alignment with the
needs of a specific tissue.
We have also demonstrated a novel role for PHA-4 in
promoting the survival of larvae during starvation. Reduced
PHA-4 levels resulted in decreased survival, while conversely
expression of PHA-4:GFP in a wild type background increased
survival. In particular, the increased survival indicates that the role
of PHA-4 in this process is a regulatable function. This function is
in keeping with its noted role in regulating environmental
responses, as well as controlling longevity and dauer formation
[16,18]. Identification of the PHA-4 binding sites under the
Figure 6. PHA-4 binding correlates with gene expression levels.
The expression levels of PHA-4 targets show that binding correlates
with increased gene expression. Genes bound by PHA-4 specifically in
embryos tend to have higher expression (indicated by increasing red
intensity) in embryos than in L1s, whereas genes bound specifically in
L1s have higher expression in larvae than in embryos. Genes bound at
both stages show a mix of expression levels.
doi:10.1371/journal.pgen.1000848.g006
Figure 7. Genes displaying RNA Pol II stalling are preferentially
bound by PHA-4. Pie charts showing the fraction of genes with an
RNA Pol II stalling index .4 [25] bound by PHA-4 for genes with either
stage-specific PHA-4 binding or shared PHA-4 binding.
doi:10.1371/journal.pgen.1000848.g007
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quite striking increase in genes involved in fatty acid metabolism
and sterol biosynthesis were seen in L1s relative to embryos.
Accordingly, many nuclear hormone receptor genes, which
encode proteins that bind steroid hormones, were preferentially
bound by PHA-4. The nuclear hormone receptor gene family in C.
elegans is much expanded relative to other organisms, and many of
the ligands for these proteins are unknown. It is possible that a
subset of these proteins respond to endogenous steroid hormones
generated in response to starvation, and that PHA-4 mediates
their induction.
Overall, the experimental ChIP-Seq pipeline we developed has
produced global binding data, expanding the view of how PHA-4
works as both a master regulator of organ development and a
mediator of starvation survival. PHA-4 primarily functions as an
activator in both situations, based on our analysis of gene
expression concomitant with binding analysis. It is likely that the
different binding patterns of PHA-4 are mediated by potential
cofactors such as SMK-1 [16], as well as interactions with other
transcription factors such as the GAGA-binding protein suggested
by the motif analysis here, and other studies [15]. The binding
sites of these factors can be identified using the tagging system and
experimental pipeline that we have established, and integrated
with the PHA-4 binding data to understand the functional
relationship of these factors. Ultimately, the global DNA binding
datasets we gather will greatly facilitate formulation of develop-
mental gene regulatory networks in C. elegans.
Materials and Methods
Clone construction and transgenesis
A 30–40 Kb fosmid containing the entire pha-4 or ama-1 locus,
along with flanking regions, was selected from an available fosmid
library (http://eleans.bcgsc.bc.ca/). Using recombineering [27], a
tag containing GFP and three tandem copies of the FLAG epitope
was engineered in frame at the carboxyl terminus of each gene.
Additionally, the marker gene unc-119 was placed into the
backbone of the fosmid (Sarov et al., in prep). The fosmid clones
containing the tagged genes were then prepped, and introduced
into unc-119(ed3) mutant worms using microparticle bombardment
[8]. Strains were tested for 100% rescue of the Unc-119
phenotype, indicating integration of the transgene. Integrated
lines were then examined by fluorescence microscopy for
expression of the tagged protein.
Starvation assays
For starvation assays with PHA-4:GFP young embryos were
released by bleach treatment and placed into modified S basal
medium at 20uC (day zero). Three samples of 30 ul each
(representing over 500 worms) were removed daily and plated
with food to determine how many animals could mature beyond
the L1 stage after two days incubation. For starvation assays using
RNAi, embryos were incubated in dsRNA according to Ahringer
[28] with the following changes. DNA template for dsRNA
synthesis was prepared by PCR. Primer sets for GFP were 59-
TAATACGACTCACTATAGGAATTTTCTGTCAGTGGAG-
AGGGTG-39 and 59-TAATACGACTCACTATAGGTCCAT-
GCCATGTGTAATCCCAG-39 and amplified from bSEM-
538(pPD126.25). Primer sets for PHA-4 were 59-TAATAC-
GACTCACTATAGG-39 and 59-TAATACGACTCACTATA-
GGGATCCAACATCCATCACGACC-39 and amplified from
bSEM865. In vitro transcription was performed using PCR
products as template with the Ampliscribe T7 Transcription Kit
(Epicentre Biotechnologies). RNA was then treated with DNase
and extracted using phenol/chloroform and ethanol precipitation.
RNA was resuspended in a final concentration of 2 ug/ul.
Gravid hermaphrodites were bleached and embryos harvested
and diluted to 100 embs/ul. In one PCR tube 2 ul RNAi soaking
buffer (1.256M9, 15 mM spermidine, 0.25% gelatin), 8 ul dsRNA
at 2 ug/ul and 1 ul of embryo suspension was added. Three tubes
per sample per day were prepared. Worms were incubated at
20uC for appropriate number of days. Day one was 24 hours after
bleaching. To determine viability, three samples were taken and
put onto plates with OP50 and are counted for worms bigger than
L1 stage 2 days later. Variability in the number of worms per plate
occurs because of pipetting variability, so numbers can go above
100% for one plate vs. the starter plate. The difference in buffers
between the two types of starvation assays altered the survival
times of worms in the two assays; animals incubated in RNAi
buffer survived longer than in S basal.
Strain growth, harvesting, and crosslinking
Liquid culture of worm strains was performed as described [9]
with some modifications. Synchronized cultures of worms were
grown on 10–20 150615 mm plates until animals were gravid.
The worms were then washed from plates using M9 buffer and
bleached to obtain embryos. Embryos were transferred to 25–
50 ml liquid media (S medium and nystatin), and incubated
overnight at 20uC at 230 rpm rotation without food to obtain a
synchronized first stage larval L1 culture. The worms were then
transferred to 500 ml S medium with the anti-fungal nystatin and
concentrated HB101, which serves as a food source. The worms
were then grown at 20uC with shaking to the desired develop-
mental stage before harvesting. Additional food was added as
necessary. For starved L1s, PHA-4:GFP worms were collected
after 6h without exposure to bacteria. To harvest, worms were
centrifuged in 50 ml conical tubes at 3000 g for 2 minutes at room
temperature. The worm pellet was then washed repeatedly with
M9 buffer and centrifuged as before until bacteria were removed.
If the sample was destined for IP followed by immunoblot, the
pellet was directly subjected to this procedure (described below). If
the sample was destined for ChIP-Seq, the sample was then
resuspended in 47 ml M9 and 2.8 ml 37% formaldehyde solution,
and crosslinked for 30 minutes at room temperature with rotation
at 50–100 rpm. The worms were then washed with 50 ml
100 mM Tris pH 7.5 to quench formaldehyde solution, washed
two times with 50 ml M9, and once with 10 ml FA buffer (50 mM
HEPES/KOH pH 7.5, 1 mM EDTA, 1% Triton X-100, 0.1%
sodium deoxycholate; 150 mM NaCl) supplemented with protease
inhibitors (Roche Cat#11697498001, cOmplete Protease Inhib-
itor Cocktail Tablets). Worms were then collected in a 15 ml
conical tube by centrifugation at 3,000g for 30s. The supernatant
was discarded and the embryo pellet was stored at 280uC.
Chromatin immunoprecipation (ChIP)
Chromatin immunoprecipitation was performed as described
[9], with the following modifications. Approximately 0.5 ml of
packed embryos/larvae was resuspended in 3 ml FA buffer plus
protease inhibitors (2 tablets protease inhibitors, 250 ul 100 mM
PMSF, 50 ul 1M DTT in 50 ml FA buffer). Using a Branson
sonifier microtip, the sample was sonicated on ice/salt water 15
times at the following settings: 50% amplitude, 10 sec on, 59.9 sec
off, avoiding overheating. Samples were transferred to microfuge
tubes and spun at 13,000g for 15 minutes at 4uC. The protein
concentration of the supernatant was then determined by Bradford
assay. Extract corresponding to ,2.2 mg of protein was added to a
microfuge tube and the volume brought to 400 ul with FA
buffer+protease inhibitors. Then 20 ul of 20% sarkosyl solution
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The supernatant was then transferred to a new tube, and 10% of
the material removed and stored at 220uC for future use as input
DNA. To the remainder, 15 ug of affinity-purified GFP (polyclonal
goat IgG; produced in Hyman lab) or control IgG antibodies was
added to the extract to detect the tagged transcription factor.
Alternatively, 10 mL of mouse ascites containing the 8WG16
mouse monoclonal antibody was added (Covance, Cat. #MMS-
126R) to detect RNA polymerase II. The immunocomplexes were
rotated at 4uC overnight (16–20 h). Then 25 ul of protein A (anti-
Pol II samples) or protein G (anti-GFP samples) conjugated to
sepharose beads (Amersham Biosciences) were added to each ChIP
sample and washed four times with 1 ml FA buffer, and spun at
2500g for 2 min to collect the beads. After the washes, the beads
were suspended in one bed volume of FA buffer, and 40 ul of the
bead slurry was added to each ChIP sample and rotated at 4uC for
2 h. The beads were then washed twice for 59 each at room
temperature in 1 ml of FA buffer and once in FA with 1M NaCl.
Each wash was gently rotated, and beads collected between each
wash by spinning for 1–2 minutes at 2500g. FA with 500 mM
NaCl was then added to the beads and the beads were transferred
to a new tube and rotated for 10 min. The beads were then
washed in TEL buffer (0.25 M LiCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0) for
10 min and twice in TE for 5 min. To elute the immunocom-
plexes, 150 ul Elution Buffer (1% SDS in TE with 250 mM NaCl)
was added and the tube incubated at 65uC for 15 min, with brief
vortexing every 5 min. The beads were spun down at 2500g for
2 min and the supernatant transferred to a new tube. The elution
was repeated and supernatants combined. At this point, input
samples were thawed and treated with the ChIP sample as follows.
To each sample, 2 ul 10 mg/ml RnaseA was added and incubated
at room temperature for 1–2 hours. Then 250 ul Elution Buffer
with 1 ul of 20 mg/ml proteinase K was added to each sample and
incubated for 1–2 hours at 55uC, then transferred to 65uC for 12–
20 h to reverse crosslinks. The DNA was then purified with the
Qiaquick PCR purification kit (Qiagen), and eluted with 50 ul
H2O. A 5 ul aliquot of the input DNA was then run on a 2%
agarose gel to check the extent of shearing, with an expected range
between 200–800 bp. The immunoprecipitated DNA was either
interrogated by qPCR or subjected to high-throughput sequencing
library preparation (below). All ChIP experiments were completed
with two or more biological replicates.
Immunoblot analysis
Immunoblotting was performed on worm lysates as well as
immunoprecipited TF/DNA complexes. Immunoblot analysis of
immunoprecipitated AMA-1:GFP and PHA-4:GFP was per-
formed on non-crossed-linked worm lysates that had been
subjected to the ChIP protocol until the multiple wash steps.
Then 50 ul lysis buffer was added to the immunocomplex bound
beads, and the beads were boiled for 5min before loading onto the
gel. Ready Gel Precast Gels (4–15% polyacrylamide) from Bio-
Rad Laboratories were used according to manufacturer’s
instructions. For AMA-1:GFP detection, anti-GFP goat polyclonal
antibody was used, and for PHA-4:GFP detection anti-GFP from
Roche (cat# 11814460001) was used, along with the species-
appropriate secondary antibodies.
qPCR analysis of ChIP products
To monitor enrichment of known or newly identified target
genes, qPCR amplification of ChIP DNA was performed. Primers
used are described in Table S1. Each PCR reaction of 10 ul was
run through the following program in a Roche LightCycler 480
machine using the SYBR Green I Master kit (Roche 04 707 516
001) according to manufacturer’s instructions. PCR program: Step
1: 95uC for 5 min; Step 2: 95uC for 30 sec; Step 3: 55uC for
30 sec, Step 4: 72uC for 1 min. Repeat steps 2–4 446; Step 5:
72uC for 5 min; Step 6: 4uC.
Library preparation for Illumina ChIP–Seq
The protocol for library preparation was adapted from the
protocol ‘‘Preparing Samples for Sequencing Genomic DNA’’ by
Illumina, and optimized with the following alterations. ChIP DNA
was end-repaired using the ‘End-It DNA End Repair Kit’ from
Epicentre, Cat#ER0720, then an ‘A’ base was added to the 39
ends of the ChIP DNA using Klenow (39 to 59; NEB Cat#
M0212s). The ChIP DNA was then ligated with the adapter mix
from the Illumina kit using LigaFast from Promega (Cat#M8221).
The DNA was then purified using the QIAquick PCR Purification
Kit and protocol between each step. The DNA was isolated from a
2% Invitrogen E-gel (Invitrogen Cat# G5018-02) by cutting a gel
slice between 150,350 bp, which excludes adapter-adapters
migrating at ,120 bp. The DNA was then purified from the gel
slice using the Qiagen Gel Extraction Kit, and subjected to PCR
amplication with Phusion DNA polymerase (NEB Cat# F-531)
and Illumina primers using the following PCR protocol: 30 sec at
98uC, [10 sec at 98uC, 30 sec at 65uC, 30 sec at 72uC] for 16
cycles, followed by 5 min at 72uC. The DNA was then purified on
a QIAquick MinElute column and the 150,350 bp band gel-
isolated. Out of a 20 ul elution, 2 ul were used to measure the
DNA concentration (ng/ul) and A260/A280 using a Nanodrop
spectrophotometer. DNA with .5 ng/ul concentration is now
ready for sequencing.
RNA isolation and RNA–Seq
Worms were grown to the desired stage and pelleted as
described above. Total RNA was extracted by TRIzol (Invitrogen)
according to the manufacturer’s protocol (TRIzol: pellet=2:1).
PolyA RNA was purified using the Applied Biosystem (Ambion)
MicroPoly(A) Purist kit. PolyA RNA was fragmented using
Fragmentation Reagent (Ambion). First strand cDNA was
synthesized from polyA RNA using a mixture of oligo dT and
random primer (Invitrogen). Double stranded cDNA synthesis was
performed using the SuperScript double stranded cDNA synthesis
kit (Invitrogen). RNA-Seq libraries were prepared for sequencing
using the Illumina protocol as described [29]. RNA-Seq scoring
was performed as previously described [30]. The RNA seq dataset
has been submitted to GEO (accession number GSE16552).
To assess the expression level of a given transcript, the DCPM
(average depth of coverage per million reads) is calculated from
RNA-Seq using a published method [30]. The change of
expression level is determined by the DCPM of each transcript
at different stages. The transcript with higher DCPM at a certain
stage will be labeled as up-regulated gene at this stage.
ChIP–Seq data processing and analysis
All mapping and analysis are based on genome WS170 of C.
elegans. The annotation of the genome includes 27,322 transcripts
(20,084 genes), which were confirmed from a previous study [30],
where most of the transcription start sites (TSS) were defined. If no
TSS was found, it was set as 150 base pairs upstream of the ATG
site.
Raw data from the Illumina Genome Analyzer I and II were
analyzed with Illumina’s Firecrest, Bustard and GERALD
modules for image analysis, basecalling and run metrics respec-
tively, and a PhiX174 control lane was used for matrix and
phasing estimations, as per the manufacturer’s instructions. Then,
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Illumina’s ELAND program in standalone mode. For each
sample, the numbers of total and mapped reads were determined
(Table S5). ChIP-Seq with two separate biological replicates with
either the anti-GFP antibody (Germany) or anti-Pol II antibody
(Clone 8WG16, Covance Research Products Inc) were pooled
together for signal calling. Significant ‘‘ChIP hits’’ were created
using a 200 bp sliding window and scoring was performed with the
PeakSeq program [20]. The hits were further filtered by using
various p-values of PeakSeq (Figure S7).
The Integrated Genome Browser (IGB, Affymetrix) was used to
view images of signal tracks and to overlay them onto the C. elegans
genome. Each GFP and POL II sample was compared over input
DNA signal. To build signal tracks for comparing samples with
different number of sequencing reads, the y-axis was normalized
for each sample according to the total number of mapped reads.
In order to show the concordance of two antibodies (anti-GFP
and anti-Pol II) for the AMA-1 binding experiments, we compared
the hits from PeakSeq with p value cut-off 0.001. Every PeakSeq
hit was divided into 600 bp bins. Then the tag count of each bin
was normalized against its background input. The normalized tag
counts of two antibodies were correlated significantly (average
correlation coefficient, R, is 0.934; Figure 2B).
To determine which genes showed elevated Pol II or GFP signal
over TSSs, we bypassed the first pass of Peak-Seq that determines
potential binding regions by simulation. Instead, we directed Peak-
Seq to examine 24,678 regions corresponding to TSS sites with a
300 bp pad on each side of the TSS. Peak-Seq was then used to
d e t e r m i n ew h e t h e rt h e s e6 0 0b pr e g i o n sw e r ee n r i c h e dr e l a t i v et o
input DNA.
All ChIP-Seq datasets have been submitted to GEO (accession
numbers GSE15535, GSE15628, GSE14545), and all tracks are
available for viewing at the modENCODE website (www.
modencode.org).
Target finding
The high genic density of the C. elegans transcriptome makes it
often the case that several genes are within a few kilobases of a
binding site, and it is necessary to select the most likely targets
amongst them. We therefore wrote an algorithm that first searches
for all transcripts within 5kb of the midpoint of a binding site. The
distance between the binding site and each transcript is computed as
one of three possibilities: binding site is upstream a certain number of
bases from the TSS, downstream a certain number of bases from the
TES, or within the gene. Transcript isoforms are then grouped into
genes assigning the distance to it as that of the closest isoform. The
genes are then ranked by the likelihood of being the target according
to the following criteria: most likely target is that which has binding
s i t ew i t h i ni t ,n e x tm o s tl i k e l yi st h a tw h i c hi sd o w n s t r e a mo ft h e
binding site (if multiple targets are downstream they are ranked by
their distance), and the least likely are those that are upstream of the
binding site (if multiple targets are upstream they are ranked by their
distance). The targets are then grouped into the following four bins:
(1) target genes which have an internal binding site or that are less
than 2kb downstream of the binding site, (2) targets that are within
2kb–5kb downstream, (3) targets that are less than 2kb upstream of
binding site, and (4) targets that are within 2kb–5kb upstream.
Finally, the binding site is said to target all genes in the first non-
empty bin. Examples of how assignment of a binding site to
candidate target genes occurs are shown in Figure S3.
Pol II stalling
To determine whether Pol II is stalled in a gene, we created a
differential signal map by subtracting the tag count of the factor
from that of the input at each position. This map was used to
calculate the average tag count for promoter regions and over the
bodies of transcripts. For this analysis, the promoter region is
defined as 6300 bp from the TSS. The transcript body is the
region 600 bp downstream of the TSS to the end of the transcript.
If the ratio of promoter:body average transcript count is greater
than 4, Pol II is considered stalled. For lower ratios, Pol II signal is
deemed to be either uniform or absent depending upon whether
Peak-Seq detected Pol II enrichment in the transcript. This is the
same method used by Zeitlinger et al. [25].
Gene Ontology (GO) analysis
A stringent q-value cut off defined by PeakSeq, 1610
25, was
used to define the genes targeted by PHA-4 in embryos and
starved L1 stages (Figure S7). The binding site has to be within or
upstream 2000 bp of the targeted gene. GoStat (http://gostat.
wehi.edu.au/cgi-bin/goStat.pl) was used for finding the over-
represented and under-represented GO terms [Table S2 (embryos)
and Table S3 (L1)]. GO categories were taken from the
‘‘biological process’’ level. 1975 and 1676 unique targeted genes
at embryonic and L1 stages are analyzed respectively, of which
1328 and 905 are annotated in the GO database for embryonic or
L1 stage. The top ten enriched GO terms at each stage are listed
in Figure 3C and 3D.
Gene Set Enrichment analysis
The same target list for GO analysis was used for Gene Set
Enrichment Analysis (GSEA) [31] in embryos. An expression
dataset of 8,769 genes were analyzed in a previous microarray
study on pharynx development in embryos, comparing two
mutants, par-1 (excess pharynx) and skn-1 (no pharynx) [14]. Of
these, 2348 are defined as PHA-4 target genes from our embryonic
target list. GSEA [31] (http://www.broad.mit.edu/gsea/) showed
significant enrichment of these targets among the up-regulated
genes, which means they are more highly expressed in par-1
embryos with excess pharynx, than in skn-1 embryos that lack
pharynx.
Motif analysis
The motif analysis was performed by MEME (http://meme.
sdsc.edu/). MEME [32] was used to discover the motifs and
generate the position weight matrices (PWMs) for PHA-4 in
embryos and starved L1s. For the embryonic stage, the input data
to MEME was the central 200 bp corresponding to the center of
the peak of the bound region. All the input sequences were sorted
by their p-values reported by PeakSeq and the top 200 sequences
were chosen for motif discovery. For the L1 stage, sorting by p-
values failed to find a significant match of the known PHA-4
consensus motif, because of a higher signal from the input sample.
Instead, sequences were sorted by their signal ratios over input and
the top 200 sequences with a more stringent window of 100 bp
were chosen.
To calculate the enrichment of the observed consensus motif,
MAST [32] was used to search for sequences that contain the
motif represented by the PWMs generated by the aforementioned.
The input data to MAST was the central 1000 bp corresponding
to the peak. All the sequences were sorted by their p-values and
the top 200 sequences were chosen. For the background, 1000 bp
was taken from 1000 bp upstream of the central for each sequence
with p-value,0.05. The p-value cutoff for each motif match was
,0.0001. The enrichment was calculated by comparing the
number of sequences matched the motif in the bound regions to
that in the background regions. The p-values of enrichment in
both embryos and L1s are close to 0.
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Figure S1 Characterization of AMA-1:GFP expressing animals.
(A) Transgenic animals express AMA-1:GFP in all nuclei,
recapitulating the wild-type expression pattern of RNA Polymer-
ase II. (B) Immunoprecipitation followed by immunoblot analysis.
AMA-1:GFP can be immunoprecipitated from worm lysates with
anti-GFP (GFP IP), which recognizes the tagged AMA-1, and anti-
Pol II (Pol II IP), which recognizes both tagged and native protein.
However, immunoblotting was performed with anti-GFP goat
polyclonal antibody, so native Pol II is not detected. Control IPs
include goat IgG (gIgG) and mouse IgG (mIgG). Total lysate
(input) was included as a control. (C) Correlation analysis of two
biological replicate ChIP-Seq experiments immunoprecipitated
with anti-GFP and anti-Pol II antibodies show high correlation
between the two IPs. (D) Correlation analysis of two biological
replicate ChIP-Seq experiments for PHA-4 in embryos and
starved L1s.
Found at: doi:10.1371/journal.pgen.1000848.s001 (3.76 MB EPS)
Figure S2 Examples of AMA-1:GFP and RNA Pol II binding at
individual loci. ChIP-Seq data acquired with anti-GFP antibody is
shown in green, anti-Pol II is shown in red, and the input signal is
shown in blue. (A,B) AMA-1:GFP and native RNA Pol II binding
at the promoters of ubc-3 and wwp-1. (C,D) AMA-1:GFP and
RNA Pol II bind throughout the gene bodies of unc-108 and ftp-1.
(E) Possible accumulation of binding at the 3’end of sulp-6. (F)
Y71G12B.6 does not display detectable AMA-1:GFP or native
RNA Pol II binding.
Found at: doi:10.1371/journal.pgen.1000848.s002 (4.44 MB EPS)
Figure S3 Diagram of how gene targets were defined.
Demonstration of how algorithm calls targets for a given binding
site. The red rectangles depict binding sites found by the PeakSeq
algorithm. Binding site A was assigned to two gene targets rfc-4
and eft-3 but not F31E3.2 (black) since it is greater than 2kb away
from the site. Binding site B was assigned only to F31E3.4.
Found at: doi:10.1371/journal.pgen.1000848.s003 (0.75 MB EPS)
Figure S4 Genes expressed in the pharynx are preferentially
bound by PHA-4 in embryos. Gene Set Enrichment Analysis
(GSEA) [27] shows that PHA-4 target genes at the embryonic
stage are highly enriched for genes up-regulated in animals with
excess pharynx relative to no pharynx [14]. 2,348 of the 8,769
genes surveyed in the previous microarray study [14] are bound by
PHA-4. The ranked expression values (log2 of par-1(excess
pharynx)/skn-1(no pharynx) of all 8769 genes are plotted from
left to right at the lower panel. The upper panel is the enrichment
score (ES), a running sum statistic beginning from the highest
ranked gene at left. ES increases when a PHA-4 target is
encountered and decreases otherwise. The ES of a set of 2,348
randomly selected genes from the 8,769 set is also presented as the
dotted line under the ES of PHA-4 targets. The normalized
enrichment score of 2348 PHA-4 targets is 2.23, with q-value less
than 0.001.
Found at: doi:10.1371/journal.pgen.1000848.s004 (0.86 MB EPS)
Figure S5 The PHA-4-binding consensus sequence is enriched
under PHA-4 binding peaks. The top three motifs are listed for
embryos and starved L1s separately. In embryos, the most conserved
sequence is GAGAGAS (S=[GC]). The second most conserved
sequence is TGTBTSY (B=[TGC],S=[GC],Y=[TC]), which
is compatible with the published motif, TRTTKRY
(R=[GA],K=[GT],Y=[TC]). The reverse-complementary se-
quence of TGTBTSY is shown in the figure of embryos. The
enrichment of this motif in embryos is 3.2. In starved L1,
TRTTKRY compatible motif is ranked at the top, with an
enrichment of 2.4.
Found at: doi:10.1371/journal.pgen.1000848.s005 (1.04 MB EPS)
Figure S6 Examples of PHA-4 binding sites at individual loci.
Genes associated with autophagy are shown. ChIP-Seq data
acquired with anti-GFP antibody is shown in green and the input
signal is shown in blue. (A–C) PHA-4:GFP binds at the promoters
of bec-1, lgg-1, and unc-51 at a very high level in starved L1
animals as compared to its binding at the same promoter regions
in embryos. (D) PHA-4:GFP binds to the promoter of gpd-2 in
starved L1 animals, but it no longer binds to that promoter in
embryos.
Found at: doi:10.1371/journal.pgen.1000848.s006 (3.51 MB EPS)
Figure S7 Binding site and gene target identification at multiple
cutoffs. Chart displaying the number of binding sites and targets as
a function of p-value determined by PeakSeq. Genes are defined as
PHA-4 targets if the binding site is within the gene or less than
2,000 base pairs upstream to the TSS (transcription start site). At
each p-value cutoff to define binding sites, the target calling
algorithm was run and the number of total targets for both embryo
and L1 samples computed. At stringent cutoffs between 1610
26 to
1610
23, each order of magnitude change in the cutoff changes the
number of targets called by about 500. The number of binding
sites also changes by about the same amount. For the analyses in
this paper, a p-value of less than 1610
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